glp-1 and sleep apnea Tirzepatide (Zepbound) – A New Treatment for Obstructive Obesity — BetterNight Frontiers | GLP-1/GIP dual agonist
Description
Learnings from this initial 3-year phase will inform the rollout to a wider group of eligible patients over a maximum period of 12 years
In recent years, the gut-brain axis has been increasingly considered a promising topic for the study of CNS-related diseases because the gut microbiota and gut hormones have been shown to interact with other organs including the brain (Knight et al., 2017), although the mechanisms involved in gut homeostasis and brain function are as yet uncharacterized (Neufeld and Foster, 2009)
Am I prepared for potential plateaus and challenges
Ni says
